JY
ZURA icon

Jeff Yass’s Zura Bio ZURA Stock Holding History

Jeff Yass’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,886
Closed -$228K – 14691
2026
Q1 		$285K Sell
47,886
-236,211
-83% -$1.43M ﹤0.01% 10974
2025
Q4 		$1.49M Buy
284,097
+36,350
+15% +$144K ﹤0.01% 6274
2025
Q3 		$1.07M Buy
247,747
+129,519
+110% +$233K ﹤0.01% 7198
2025
Q2 		$124K Buy
118,228
+53,186
+82% +$63.6K ﹤0.01% 11650
2025
Q1 		$83.9K Buy
65,042
+40,476
+165% +$63.8K ﹤0.01% 11648
2024
Q4 		$61.4K Sell
24,566
-33,292
-58% -$119K ﹤0.01% 11594
2024
Q3 		$235K Buy
+57,858
New +$216K ﹤0.01% 10134
2024
Q1 		– Sell
-12,037
Closed -$56.2K – 13534
2023
Q4 		$56.2K Buy
+12,037
New +$60.2K ﹤0.01% 11670

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jeff Yass's ZURA Position: Q2 2026 in Review

Jeff Yass sold out of Zura Bio (ZURA) in Q2 2026, closing a stake of 47,886 shares — an estimated $228K sold.

Jeff Yass first reported a position in ZURA in Q4 2023 and held it in 8 quarters. The position peaked at $1.49M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Jeff Yass reported no remaining Zura Bio position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 47,886 Zura Bio shares in Q2 2026, an estimated $228K.
  • Jeff Yass first reported a position in Zura Bio in Q4 2023 and held it in 8 quarters.
  • Jeff Yass's Zura Bio position peaked at $1.49M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.